Chromogranin A and neurone‐specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration‐resistant prostate cancer
Liancheng Fan; Yanqing Wang; Chenfei Chi; Jiahua Pan; Shangguan Xun; Zhixiang Xin; Jianian Hu; Lixin Zhou; Baijun Dong; Wei Xue
Author Information: Department of Urology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.